NCT06025201

Brief Summary

Chronic low back pain (CLBP) is a pervasive disorder affecting up to one-fifth of adults globally and is the single greatest cause of disability worldwide. Despite the high prevalence and detrimental impact of CLBP, its treatments and mechanisms remain largely unclear. Biomarkers that predict symptom progression in CLBP support precision-based treatments and ultimately aid in reducing suffering. Longitudinal brain-based resting-state neuroimaging of patients with CLBP has revealed neural networks that predict pain chronification and its symptom progression. Although early findings suggest that measurements of brain networks can lead to the development of prognostic biomarkers, the predictive ability of these models is strongest for short-term follow-up. Measurements of different neural systems may provide additional benefits with better predictive power. Emotional and cognitive dysfunction is common in CLBP, occurring at the behavioral and cerebral level, presenting a unique opportunity to detect prognostic brain-based biomarkers. Likewise, improvements in electroencephalogram (EEG) neuroimaging strategies have led to increased spatial resolution, enabling researchers to overcome the limitations of classically used neuroimaging modalities (e.g., magnetic resonance imaging \[MRI\] and functional MRI), such as high cost and limited accessibility. Using longitudinal EEG, this patient-oriented research project will provide a comprehensive neural picture of emotional, cognitive, and resting-state networks in patients with CLBP, which will aid in predicting symptom progression in CLBP. Through this award, the investigators will use modern EEG source analysis strategies to track biomarkers at baseline and 1- and 2-month follow-ups and their covariance with markers for pain and emotional and cognitive dysfunction. A 5-month follow up will also be used to only assess patient reported outcomes. In Aim 1, the investigators will identify and characterize differences in resting-state, emotional, and cognitive networks between patients with CLPB and age/sex-matched controls. In Aim 2, the investigators will identify within-subject changes across time and their relationship with clinical symptoms. In Aim 3, as an exploratory aim, the investigators will apply machine- and deep-learning strategies to detect a comprehensive signature of CLBP using EEG features from resting-state, emotional, and cognitive networks.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
27mo left

Started Dec 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Dec 2023Aug 2028

First Submitted

Initial submission to the registry

August 24, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 6, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

December 15, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2028

Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

3 years

First QC Date

August 24, 2023

Last Update Submit

January 20, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Pain Intensity changes from baseline as assessed by the PROMIS current, 7 day maximal and 7 day average

    Within subjects change in pain intensity from baseline to each follow up point. Pain intensity measures are 0-10 range with larger numbers indicating more pain

    Baseline, 1-month, 2-month and 5-month follow-ups

  • EEG resting state functional connectivity changes from baseline

    Within subjects change in resting state functional connectivity from baseline to each follow up point.

    Baseline, 1-month and 2-month follow-ups

  • EEG late positive potential changes from baseline

    Within subjects change in late positive potential from baseline to each follow up point.

    Baseline, 1-month and 2-month follow-ups

  • EEG error related negativity changes from baseline

    Within subjects change in error related negativity from baseline to each follow up point.

    Baseline, 1-month and 2-month follow-ups

Secondary Outcomes (1)

  • Neuropsychological changes from baseline as assessed by the NIH toolbox

    Baseline, 1-month and 2-month follow-ups

Study Arms (1)

Single Arm

EXPERIMENTAL

All participants will complete all interventions

Behavioral: Resting State EEGBehavioral: Picture Viewing EEGBehavioral: Stop Signal EEG

Interventions

During this intervention, participants will be asked to not think about anything in particular while EEG is recorded. Resting state will be conducted with either the participants having their eyes open, or eyes closed.

Single Arm

During this intervention, participants will view emotionally charged pictures for a short period of time. Afterwards, participants will be asked to rate their emotional reactions to the pictures. EEG will be recorded during this intervention.

Single Arm
Stop Signal EEGBEHAVIORAL

During this intervention, participants will be asked to respond quickly to a visual stimulus with a button press. At times, participants will be asked to inhibit their responses. EEG will be recorded during this intervention.

Single Arm

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Current diagnosis of Chronic Low Back Pain

You may not qualify if:

  • Current diagnosis of cancer
  • Severe psychiatric conditions
  • Pending personal litigation relating to an injury or receiving workers' compensation benefits
  • Being a non-English speaker.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford's Systems and Neuroscience Pain Lab

Palo Alto, California, 94304, United States

RECRUITING

Central Study Contacts

Omar Altirkawi

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: All participants will complete all interventions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pain Psychologist

Study Record Dates

First Submitted

August 24, 2023

First Posted

September 6, 2023

Study Start

December 15, 2023

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

August 1, 2028

Last Updated

January 22, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

The investigators will support requests for data sharing in a timely manner. Prior to sharing data, the data will be redacted of all personal identifiers to prevent subject identification.

Locations